{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:47Z","timestamp":1792788107449,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guizhou Province Science and Technology Program","award":["Qiankehe support [2023] General 071"],"award-info":[{"award-number":["Qiankehe support [2023] General 071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drunkenness and alcoholic liver disease (ALD) are critical public health issues associated with significant morbidity and mortality due to chronic overconsumption of alcohol. Traditional remedies, such as bear bile powder, have been historically acclaimed for their hepatoprotective properties. This study assessed the efficacy of a biotransformed bear bile powder known as golden bile powder (GBP) in alleviating alcohol-induced drunkenness and ALD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A murine model was engineered to simulate alcohol drunkenness and acute hepatic injury through the administration of a 50% ethanol solution. Intervention with GBP and its effects on alcohol-related symptoms were scrutinized, by employing an integrative approach that encompasses serum metabolomics, network medicine, and gut microbiota profiling to elucidate the protective mechanisms of GBP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GBP administration significantly delayed the onset of drunkenness and decreased the duration of ethanol-induced inebriation in mice. Enhanced liver cell recovery was indicated by increased hepatic aldehyde dehydrogenase levels and superoxide dismutase activity, along with significant decreases in the serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, triglyceride, and total cholesterol levels (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). These biochemical alterations suggest diminished hepatic damage and enhanced lipid homeostasis. Microbiota analysis via 16S rDNA sequencing revealed significant changes in gut microbial diversity and composition following alcohol exposure, and these changes were effectively reversed by GBP treatment. Metabolomic analyses demonstrated that GBP normalized the alcohol-induced perturbations in phospholipids, fatty acids, and bile acids. Correlation assessments linked distinct microbial genera to serum bile acid profiles, indicating that the protective efficacy of GBP may be attributable to modulatory effects on metabolism and the gut microbiota composition. Network medicine insights suggest the prominence of two active agents in GBP as critical for addressing drunkenness and ALD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GBP is a potent intervention for alcohol-induced pathology and offers hepatoprotective benefits, at least in part, through the modulation of the gut microbiota and related metabolic cascades.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-024-00912-2","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T02:01:53Z","timestamp":1709344913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Golden bile powder prevents drunkenness and alcohol-induced liver injury in mice via the gut microbiota and metabolic modulation"],"prefix":"10.1186","volume":"19","author":[{"given":"Yarong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhuang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7639-2456","authenticated-orcid":false,"given":"Guozhen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"issue":"1","key":"912_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, et al. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4(1):16.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"912_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/ijms23020774","volume":"23","author":"YM Yang","year":"2022","unstructured":"Yang YM, Cho YE, Hwang S. Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease. Int J Mol Sci. 2022;23(2):774.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"912_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200\u201316.","journal-title":"Nat Rev Drug Discov"},{"key":"912_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1746-4269-5-2","volume":"5","author":"Y Feng","year":"2009","unstructured":"Feng Y, Siu K, Wang N, et al. Bear bile: dilemma of traditional medicinal use and animal protection. J Ethnobiol Ethnomed. 2009;5:2.","journal-title":"J Ethnobiol Ethnomed"},{"key":"912_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115640","volume":"168","author":"S Jiang","year":"2023","unstructured":"Jiang S, Wei X, Zhang Y, et al. Biotransformed bear bile powder ameliorates diet-induced nonalcoholic steatohepatitis in mice through modulating arginine biosynthesis via FXR\/PXR-PI3K-AKT-NOS3 axis. Biomed Pharmacother. 2023;168: 115640.","journal-title":"Biomed Pharmacother"},{"key":"912_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115875","volume":"218","author":"H Han","year":"2023","unstructured":"Han H, Zhao C, Liu M, et al. Mitochondrial complex I inhibition by homoharringtonine: a novel strategy for suppression of chronic myeloid leukemia. Biochem Pharmacol. 2023;218: 115875.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"912_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.12938\/bmfh.2022-005","volume":"42","author":"T Huang","year":"2023","unstructured":"Huang T, Jiang J, Cao Y, et al. Camellia oil (Camellia oleifera Abel) treatment improves high-fat diet-induced atherosclerosis in apolipoprotein E (ApoE)\u2212\/\u2212 mice. Biosci Microb Food Health. 2023;42(1):56\u201364.","journal-title":"Biosci Microb Food Health"},{"issue":"1","key":"912_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13020-023-00814-9","volume":"18","author":"A Ren","year":"2023","unstructured":"Ren A, Wu T, Wang Y, et al. Integrating animal experiments, mass spectrometry and network-based approach to reveal the sleep-improving effects of Ziziphi Spinosae Semen and gamma-aminobutyric acid mixture. Chin Med. 2023;18(1):99.","journal-title":"Chin Med"},{"issue":"10","key":"912_CR9","doi-asserted-by":"publisher","first-page":"063","DOI":"10.1093\/femsle\/fnab063","volume":"368","author":"T Huang","year":"2021","unstructured":"Huang T, Zhou W, Ma X, et al. Oral administration of camellia oil ameliorates obesity and modifies the gut microbiota composition in mice fed a high-fat diet. FEMS Microbiol Lett. 2021;368(10):063.","journal-title":"FEMS Microbiol Lett"},{"issue":"D1","key":"912_CR10","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2015","unstructured":"Gilson MK, Liu T, Baitaluk M, et al. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucl Acids Res. 2015;44(D1):D1045\u201353.","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"912_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, et al. DrugBank 5.0: a major update to the drugbank database for 2018. Nucl Acids Res. 2018;46(D1):1074\u201382.","journal-title":"Nucl Acids Res"},{"issue":"4","key":"912_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2013","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr, et al. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2013;30(4):523\u20135530.","journal-title":"Bioinformatics"},{"key":"912_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad751","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhang Y, Zhao D, et al. TTD: therapeutic target database describing target druggability information. Nucl Acids Res. 2023. https:\/\/doi.org\/10.1093\/nar\/gkad751.","journal-title":"Nucl Acids Res"},{"key":"912_CR14","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/nar\/gkad944","volume":"52","author":"SD Harding","year":"2023","unstructured":"Harding SD, Armstrong JF, Faccenda E, et al. The IUPHAR\/BPS guide to pharmaCOLOGY in 2024. Nucl Acids Res. 2023;52:1438.","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"912_CR15","doi-asserted-by":"publisher","first-page":"D1257","DOI":"10.1093\/nar\/gkac833","volume":"51","author":"AP Davis","year":"2022","unstructured":"Davis AP, Wiegers TC, Johnson RJ, et al. Comparative toxicogenomics database (CTD): update 2023. Nucleic Acids Res. 2022;51(D1):D1257\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"912_CR16","doi-asserted-by":"publisher","first-page":"D1238","DOI":"10.1093\/nar\/gkab1011","volume":"50","author":"D Yan","year":"2021","unstructured":"Yan D, Zheng G, Wang C, et al. HIT 2.0: an enhanced platform for herbal ingredients targets. Nucl Acids Res. 2021;50(D1):D1238\u201343.","journal-title":"Nucl Acids Res"},{"issue":"1","key":"912_CR17","doi-asserted-by":"publisher","first-page":"1.301","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform. 2016;54(1):1.301-1.3.","journal-title":"Curr Protoc Bioinform"},{"issue":"D1","key":"912_CR18","first-page":"D845","volume":"48","author":"J Pi\u00f1ero","year":"2019","unstructured":"Pi\u00f1ero J, Ram\u00edrez-Anguita JM, Sa\u00fcch-Pitarch J, et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucl Acids Res. 2019;48(D1):D845\u201355.","journal-title":"Nucl Acids Res"},{"issue":"1","key":"912_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cpbi.27","volume":"58","author":"JS Amberger","year":"2017","unstructured":"Amberger JS, Hamosh A. Searching Online Mendelian inheritance in man (OMIM): a knowledgebase of human genes and genetic phenotypes. Curr Protoc Bioinform. 2017;58(1):121\u2013212.","journal-title":"Curr Protoc Bioinform"},{"issue":"7803","key":"912_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-020-2188-x","volume":"580","author":"K Luck","year":"2020","unstructured":"Luck K, Kim D-K, Lambourne L, et al. A reference map of the human binary protein interactome. Nature. 2020;580(7803):402\u20138.","journal-title":"Nature"},{"issue":"11","key":"912_CR21","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","volume":"184","author":"EL Huttlin","year":"2021","unstructured":"Huttlin EL, Bruckner RJ, Navarrete-Perea J, et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell. 2021;184(11):3022-40.e28.","journal-title":"Cell"},{"key":"912_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s43016-021-00243-7","author":"IF do Valle","year":"2021","unstructured":"do Valle IF, Roweth HG, Malloy MW, et al. Network medicine framework shows that proximity of polyphenol targets and disease proteins predicts therapeutic effects of polyphenols. Nat Food. 2021. https:\/\/doi.org\/10.1038\/s43016-021-00243-7.","journal-title":"Nat Food"},{"issue":"1","key":"912_CR23","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1038\/s41467-018-05116-5","volume":"9","author":"F Cheng","year":"2018","unstructured":"Cheng F, Desai RJ, Handy DE, et al. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun. 2018;9(1):2691.","journal-title":"Nat Commun"},{"key":"912_CR24","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.1038\/ncomms10331","volume":"7","author":"E Guney","year":"2016","unstructured":"Guney E, Menche J, Vidal M, et al. Network-based in silico drug efficacy screening. Nat Commun. 2016;7:10331.","journal-title":"Nat Commun"},{"issue":"1","key":"912_CR25","volume":"4","author":"A Ren","year":"2024","unstructured":"Ren A, Ma M, Liang Y, et al. GSZ formula enhances sleep quality: exploring its active ingredients and mechanism using a network medicine approach. Clin Comple Med Pharmacol. 2024;4(1): 100107.","journal-title":"Clin Comple Med Pharmacol"},{"issue":"2","key":"912_CR26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/apt.14397","volume":"47","author":"CA Woodhouse","year":"2018","unstructured":"Woodhouse CA, Patel VC, Singanayagam A, et al. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Aliment Pharmacol Ther. 2018;47(2):192\u2013202.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"912_CR27","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1021\/acs.jproteome.3c00093","volume":"22","author":"T Zhang","year":"2023","unstructured":"Zhang T, Bao L, Zhao Q, et al. Metabolomics reveals gut microbiota contribute to pparalpha deficiency-induced alcoholic liver injury. J Proteome Res. 2023;22(7):2327\u201338.","journal-title":"J Proteome Res"},{"issue":"1","key":"912_CR28","doi-asserted-by":"publisher","first-page":"2300301","DOI":"10.1002\/mnfr.202300301","volume":"68","author":"Y Cui","year":"2023","unstructured":"Cui Y, Jing C, Yue Y, et al. Kefir ameliorates alcohol-induced liver injury through modulating gut microbiota and fecal bile acid profile in mice. Mol Nutr Food Res. 2023;68(1):2300301.","journal-title":"Mol Nutr Food Res."},{"issue":"5","key":"912_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS, Heuman DM, Hylemon PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2014;60(5):940\u20137.","journal-title":"J Hepatol"},{"issue":"6","key":"912_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01926-22","volume":"10","author":"S Li","year":"2022","unstructured":"Li S, Guo J, Liu R, et al. Predominance of Escherichia-Shigella in gut microbiome and its potential correlation with elevated level of plasma tumor necrosis factor alpha in patients with Tuberculous Meningitis. Microbiol Spectr. 2022;10(6): e0192622.","journal-title":"Microbiol Spectr"},{"issue":"6","key":"912_CR31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/microorganisms10061231","volume":"10","author":"TA Baltazar-Diaz","year":"2022","unstructured":"Baltazar-Diaz TA, Gonzalez-Hernandez LA, Aldana-Ledesma JM, et al. Escherichia\/Shigella, SCFAs, and metabolic pathways-the triad that orchestrates intestinal dysbiosis in patients with decompensated alcoholic cirrhosis from Western Mexico. Microorganisms. 2022;10(6):1231.","journal-title":"Microorganisms."},{"issue":"2","key":"912_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1530\/JOE-13-0109","volume":"218","author":"E Maneschi","year":"2013","unstructured":"Maneschi E, Vignozzi L, Morelli A, et al. FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. J Endocrinol. 2013;218(2):215\u201331.","journal-title":"J Endocrinol"},{"issue":"2","key":"912_CR33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.apsb.2014.12.011","volume":"5","author":"S Manley","year":"2015","unstructured":"Manley S, Ding W. Role of farnesoid X receptor and bile acids in alcoholic liver disease. J Acta pharmaceutica Sinica B. 2015;5(2):158\u201367.","journal-title":"J Acta pharmaceutica Sinica B"},{"issue":"32","key":"912_CR34","doi-asserted-by":"publisher","first-page":"29342","DOI":"10.1074\/jbc.M202411200","volume":"277","author":"M You","year":"2002","unstructured":"You M, Fischer M, Deeg MA, et al. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem. 2002;277(32):29342\u20137.","journal-title":"J Biol Chem"},{"issue":"6","key":"912_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100479","volume":"4","author":"B Paul","year":"2022","unstructured":"Paul B, Lewinska M, Andersen JB. Lipid alterations in chronic liver disease and liver cancer. JHEP Rep. 2022;4(6): 100479.","journal-title":"JHEP Rep"},{"issue":"3","key":"912_CR36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ajpath.2011.11.017","volume":"180","author":"W Zhong","year":"2012","unstructured":"Zhong W, Zhao Y, Tang Y, et al. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol. 2012;180(3):998\u20131007.","journal-title":"Am J Pathol"},{"issue":"9","key":"912_CR37","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1096\/fj.13-231860","volume":"27","author":"G Xie","year":"2013","unstructured":"Xie G, Zhong W, Li H, et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption. FASEB J. 2013;27(9):3583\u201393.","journal-title":"FASEB J"},{"key":"912_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.109931","volume":"360","author":"G Charkoftaki","year":"2022","unstructured":"Charkoftaki G, Tan WY, Berrios-Carcamo P, et al. Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice. Chem Biol Interact. 2022;360: 109931.","journal-title":"Chem Biol Interact"},{"issue":"4","key":"912_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.dld.2018.12.026","volume":"51","author":"B Kong","year":"2019","unstructured":"Kong B, Zhang M, Huang M, et al. FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury. Dig Liver Dis. 2019;51(4):570\u20136.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"912_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/alcalc\/agaa005","volume":"55","author":"X Gong","year":"2020","unstructured":"Gong X, Zhang Q, Ruan Y, et al. Chronic alcohol consumption increased bile acid levels in enterohepatic circulation and reduced efficacy of irinotecan. Alcohol Alcohol. 2020;55(3):264\u201377.","journal-title":"Alcohol Alcohol"},{"issue":"5","key":"912_CR41","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41401-022-00880-z","volume":"43","author":"TY Jiao","year":"2022","unstructured":"Jiao TY, Ma YD, Guo XZ, et al. Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease. Acta Pharmacol Sin. 2022;43(5):1103\u201319.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"912_CR42","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, et al. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678\u201393.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"912_CR43","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1080\/00498254.2020.1761571","volume":"50","author":"G Kubiak-Tomaszewska","year":"2020","unstructured":"Kubiak-Tomaszewska G, Tomaszewski P, Pachecka J, et al. Molecular mechanisms of ethanol biotransformation: enzymes of oxidative and nonoxidative metabolic pathways in human. Xenobiotica. 2020;50(10):1180\u2013201.","journal-title":"Xenobiotica"},{"issue":"10","key":"912_CR44","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1073\/pnas.1414657112","volume":"112","author":"CH Chen","year":"2015","unstructured":"Chen CH, Cruz LA, Mochly-Rosen D. Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo. Proc Natl Acad Sci USA. 2015;112(10):3074\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"912_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40168-017-0359-2","volume":"5","author":"VB Dubinkina","year":"2017","unstructured":"Dubinkina VB, Tyakht AV, Odintsova VY, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5(1):141.","journal-title":"Microbiome"},{"issue":"2","key":"912_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100220","volume":"3","author":"B Fairfield","year":"2021","unstructured":"Fairfield B, Schnabl B. Gut dysbiosis as a driver in alcohol-induced liver injury. JHEP Rep. 2021;3(2): 100220.","journal-title":"JHEP Rep"},{"issue":"1","key":"912_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13613-023-01198-7","volume":"13","author":"A Greimel","year":"2023","unstructured":"Greimel A, Habler K, Grafe C, et al. Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study. Ann Intensive Care. 2023;13(1):110.","journal-title":"Ann Intensive Care"},{"issue":"7","key":"912_CR48","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1039\/D0FO00795A","volume":"11","author":"K Xie","year":"2020","unstructured":"Xie K, He X, Chen K, et al. Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD. Food Funct. 2020;11(7):5976\u201391.","journal-title":"Food Funct"},{"key":"912_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2022.109061","volume":"107","author":"P Guo","year":"2022","unstructured":"Guo P, Xue M, Teng X, et al. Antarctic krill oil ameliorates liver injury in rats exposed to alcohol by regulating bile acids metabolism and gut microbiota. J Nutr Biochem. 2022;107: 109061.","journal-title":"J Nutr Biochem"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-024-00912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-024-00912-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-024-00912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T02:05:27Z","timestamp":1709345127000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-024-00912-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["912"],"URL":"https:\/\/doi.org\/10.1186\/s13020-024-00912-2","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"31 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}